by Plus Therapeutics | Feb 1, 2025 | GBM, LM, PBC, Uncategorized
A Heartfelt Thank You to Our ReSPECT-GBM & ReSPECT-LM Clinical Trial Participants To every patient who has participated in the ReSPECT-GBM and ReSPECT-LM clinical trials: THANK YOU! 💙 Your courage and commitment are helping advance critical research for recurrent...
by Plus Therapeutics | Jan 14, 2025 | GBM
ReSPECT-GBM Clinical Trial Update: Phase 2 Enrollment Now Open We are excited to announce that enrollment for the Phase 1 ReSPECT-GBM clinical trial is complete! We are actively enrolling patients for Phase 2 of the trial, which focuses on treating recurrent...
by Plus Therapeutics | Dec 19, 2024 | GBM
🎗️ Now Streaming: ReSPECT-GBM Patient Story – Jim’s Journey as a Recurrent Glioblastoma Survivor Watch Jim’s Inspiring Story Now on YouTube: Watch Jim’s Story Dr. Jim Stockand, a dedicated educator with a PhD in Physiology, has devoted the past 24 years to...
by Plus Therapeutics | Dec 18, 2024 | GBM
❗NEW CLINICAL TRIAL SITE NOW ENROLLING PATIENTS: ReSPECT-GBM at North Shore University Hospital❗ We are excited to announce a new clinical trial investigation site for the ReSPECT-GBM clinical trial: North Shore University Hospital @NorthwellHealth in New York. Under...
by Plus Therapeutics | Dec 16, 2024 | GBM
COMING SOON: A Glioblastoma Survivor’s Journey with ReSPECT-GBM This week, we are thrilled to share a BRAND NEW patient testimonial from Jim, a courageous individual who has been navigating the challenges of recurrent glioblastoma. In this powerful video, Jim...
by Plus Therapeutics | Nov 15, 2024 | GBM
Plus Therapeutics at the ABTA Race in New York: Supporting Brain Cancer Awareness and Education Check out this photo of our dedicated patient advocacy team at the @the_ABTA race in New York last weekend! The Plus Therapeutics team was proud to support and participate...
Recent Comments